Denali Therapeutics Inc.

07/15/2021 | Press release | Distributed by Public on 07/15/2021 07:07

Denali Therapeutics to Present Interim Data from Phase 1/2 Study of ETV:IDS (DNL310) for the Potential Treatment of Hunter Syndrome at MPS 2021